Assignment of Assignor's Interest

Recorded: 2017-03-13 Pages: 7

Assignor

OCULEX PHARMACEUTICALS, INC.

Executed: 2003-12-18

Assignee

ALLERGAN, INC.

2525 DUPONT DRIVE, T2-7H, IRVINE, CALIFORNIA, 92612-1599

Covered Property (1)

Methods for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor

Application: 15/457,516 →

Publication: US 2017/0182064

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.